UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical recurrences of COVID-19 symptoms after recovery: Viral relapse, reinfection or inflammatory rebound?

The Journal of infection, 2020-11, Vol.81 (5), p.816-846

2020

Volltextzugriff (PDF)

Discrepant responses to triple combination antiretroviral therapy in advanced HIV disease

AIDS (London), 1998-05, Vol.12 (7), p.745-750

1998

Volltextzugriff (PDF)

HIV infection and COVID-19: risk factors for severe disease

AIDS (London), 2020-10, Vol.34 (12), p.1771-1774

2020

Volltextzugriff (PDF)

Clinical, virological and imaging profile in patients with prolonged forms of COVID-19: A cross-sectional study

The Journal of infection, 2021-02, Vol.82 (2), p.e1-e4

2021

Volltextzugriff (PDF)

Acquired hemophilia A resolution in a hepatitis C virus/human immunodeficiency virus–coinfected patient with cure of hepatitis C by direct‐acting antiviral agents

Hepatology (Baltimore, Md.), 2018-02, Vol.67 (2), p.794-796

2018

Volltextzugriff (PDF)

Real-World Efficacy of Daclatasvir and Sofosbuvir, With and Without Ribavirin, in HIV/HCV Coinfected Patients With Advanced Liver Disease in a French Early Access Cohort

Journal of acquired immune deficiency syndromes (1999), 2017-05, Vol.75 (1), p.97-107

2017

Volltextzugriff (PDF)

Facial skin pores: a multiethnic study

Clinical, cosmetic and investigational dermatology, 2015-01, Vol.8 (default), p.85-93

2015

Volltextzugriff (PDF)

Telaprevir for HIV/Hepatitis C Virus–Coinfected Patients Failing Treatment With Pegylated Interferon/Ribavirin (ANRS HC26 TelapreVIH): An Open-Label, Single-Arm, Phase 2 Trial

Clinical infectious diseases, 2014-12, Vol.59 (12), p.1768-1776

2014

Volltextzugriff (PDF)

Efficacy, safety and patient‐reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor‐experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study)

HIV medicine, 2018-03, Vol.19 (3), p.227-237

2018

Volltextzugriff (PDF)

Late Antiretroviral Therapy (ART) Initiation Is Associated with Long-Term Persistence of Systemic Inflammation and Metabolic Abnormalities

PloS one, 2015-12, Vol.10 (12), p.e0144317-e0144317

2015

Volltextzugriff (PDF)

High frequency of integrase Q148R minority variants in HIV-infected patients naive of integrase inhibitors

AIDS (London), 2010-03, Vol.24 (6), p.867-873

2010

Volltextzugriff (PDF)

Sexually transmitted acute infection with a clustered genotype 4 hepatitis C virus in HIV-1-infected men and inefficacy of early antiviral therapy

AIDS (London), 2006-01, Vol.20 (2), p.233-240

2006

Volltextzugriff (PDF)

Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infection

Journal of hepatology, 2010-08, Vol.53 (2), p.238-244

2010

Volltextzugriff (PDF)

Soutenir une autorité fragile

Enfances & psy, 2003, Vol.no22 (2), p.108-117

Batisse, Dominique

2003

Volltextzugriff (PDF)

A computational skin model: fold and wrinkle formation

IEEE journal of biomedical and health informatics, 2002-12, Vol.6 (4), p.317-323

2002

Volltextzugriff (PDF)

Raltegravir-based regimens are effective in HIV-1 group O-infected patients

Journal of acquired immune deficiency syndromes (1999), 2012-09, Vol.61 (1), p.e1-e3

2012

Volltextzugriff (PDF)

Telaprevir enhances ribavirin-induced anaemia through renal function impairment

Antiviral therapy, 2015-01, Vol.20 (5), p.479-486

2015

Volltextzugriff (PDF)

Capacitance imaging of the skin surface

Skin research and technology, 2006-05, Vol.12 (2), p.99-104

2006

Volltextzugriff (PDF)

Long-term efficacy of combination therapy with interferon-α2b and ribavirin for severe chronic hepatitis C in HIV-infected patients

AIDS (London), 2001-11, Vol.15 (16), p.2149-2155

2001

Volltextzugriff (PDF)

Optimization and robustness of blood tests for liver fibrosis and cirrhosis

Clinical biochemistry, 2010-11, Vol.43 (16), p.1315-1322

2010

Volltextzugriff (PDF)

Influence of age on the wrinkling capacities of skin

Skin research and technology, 2002-08, Vol.8 (3), p.148-154

2002

Volltextzugriff (PDF)

Sustained exacerbation of cryoglobulinaemia-related vasculitis following treatment of hepatitis C with peginterferon alfa

European journal of gastroenterology & hepatology, 2004-07, Vol.16 (7), p.701-703

2004

Volltextzugriff (PDF)

Efficacy and safety of combination therapy with interferon-α2b and ribavirin for chronic hepatitis C in HIV-infected patients

AIDS (London), 2000-05, Vol.14 (7), p.839-844

2000

Volltextzugriff (PDF)

Alteration of cytochrome oxidase subunit I labeling is associated with severe mitochondriopathy in NRTI-related hepatotoxicity in HIV patients

Modern pathology, 2006-10, Vol.19 (10), p.1277-1288

2006

Volltextzugriff (PDF)

Lack of interference between ribavirin and nucleosidic analogues in HIV/HCV co-infected individuals undergoing concomitant antiretroviral and anti-HCV combination therapy

AIDS (London), 2000-08, Vol.14 (12), p.1857-1858

2000

Volltextzugriff (PDF)

1 – 25 von 45

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(37)

Publikationsform

Artikel
(45)

Sprache

Englisch
(40)
Französisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinical recurrences of COVID-19 symptoms after recovery: Viral relapse, reinfection or inflammatory rebound?

Discrepant responses to triple combination antiretroviral therapy in advanced HIV disease

HIV infection and COVID-19: risk factors for severe disease

Clinical, virological and imaging profile in patients with prolonged forms of COVID-19: A cross-sectional study

Acquired hemophilia A resolution in a hepatitis C virus/human immunodeficiency virus–coinfected patient with cure of hepatitis C by direct‐acting antiviral agents

Real-World Efficacy of Daclatasvir and Sofosbuvir, With and Without Ribavirin, in HIV/HCV Coinfected Patients With Advanced Liver Disease in a French Early Access Cohort

Facial skin pores: a multiethnic study

Telaprevir for HIV/Hepatitis C Virus–Coinfected Patients Failing Treatment With Pegylated Interferon/Ribavirin (ANRS HC26 TelapreVIH): An Open-Label, Single-Arm, Phase 2 Trial

Efficacy, safety and patient‐reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor‐experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study)

Late Antiretroviral Therapy (ART) Initiation Is Associated with Long-Term Persistence of Systemic Inflammation and Metabolic Abnormalities

High frequency of integrase Q148R minority variants in HIV-infected patients naive of integrase inhibitors

Sexually transmitted acute infection with a clustered genotype 4 hepatitis C virus in HIV-1-infected men and inefficacy of early antiviral therapy

Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infection

Soutenir une autorité fragile

A computational skin model: fold and wrinkle formation

Raltegravir-based regimens are effective in HIV-1 group O-infected patients

Telaprevir enhances ribavirin-induced anaemia through renal function impairment

Capacitance imaging of the skin surface

Long-term efficacy of combination therapy with interferon-α2b and ribavirin for severe chronic hepatitis C in HIV-infected patients

Optimization and robustness of blood tests for liver fibrosis and cirrhosis

Influence of age on the wrinkling capacities of skin

Sustained exacerbation of cryoglobulinaemia-related vasculitis following treatment of hepatitis C with peginterferon alfa

Efficacy and safety of combination therapy with interferon-α2b and ribavirin for chronic hepatitis C in HIV-infected patients

Alteration of cytochrome oxidase subunit I labeling is associated with severe mitochondriopathy in NRTI-related hepatotoxicity in HIV patients

Lack of interference between ribavirin and nucleosidic analogues in HIV/HCV co-infected individuals undergoing concomitant antiretroviral and anti-HCV combination therapy

Suchergebnisse filtern